Biopharmx Corporatio (BPMX) 1.19 $BPMX
BioPharmX Corporation Expands Management Team to Support Growth and Market Expansion
PR Newswire - Tue Sep 29, 8:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focusing on women's health and dermatology, today announced the appointment of two executives to strengthen the company's operations and marketing efforts.
BPMX: 1.19 (-0.01)
StockNewsNow.com Publishes New SNNLive Video Interview With BioPharmX Corporation
Marketwired - Thu Sep 24, 7:00AM CDT
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Jim Pekarsky, CEO of BioPharmX Corporation (NYSE MKT: BPMX), a Silicon Valley-based specialty pharmaceutical company, according to the company's website (see here: www.BioPharmX.com). The video interview was recorded on Wednesday, Sept. 9, 2015 in New York City.
BPMX: 1.19 (-0.01)
Survey Shows Most U.S. Women Suffer from Premenstrual Breast Discomfort
PR Newswire - Tue Sep 22, 6:30AM CDT
As the public focuses on breast health in advance of Breast Cancer Awareness Month, newly released survey results find that most American women endure breast discomfort during their menstrual years, but do not know how to treat it or improve the health of their breasts.
BPMX: 1.19 (-0.01)
BioPharmX Corporation Reports Second Quarter Results
PR Newswire - Mon Sep 14, 3:05PM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a Silicon Valley-based specialty pharmaceutical company, today announced its financial results for the fiscal quarter ended July 31, 2015. An earnings conference call is scheduled for today at 4:30 p.m. Eastern Time.
BPMX: 1.19 (-0.01)
BioPharmX Corporation to Release Second Quarter 2016 Financial Results
PR Newswire - Wed Sep 09, 7:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) today announced it will release its financial results for second quarter ended July 31, 2015 and will host an earnings conference call at 4:30 p.m. Eastern Time on Monday, September 14, 2015.
BPMX: 1.19 (-0.01)
Seasoned Silicon Valley Financial Executive Joins BioPharmX Corporation As Chief Financial Officer
PR Newswire - Wed Aug 12, 7:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a Silicon Valley-based specialty pharmaceutical company, has appointed 20-year finance veteran Greg Kitchener, to be executive vice president of finance and chief financial officer.
BPMX: 1.19 (-0.01)
BioPharmX Corporation Launches Grocery Store Distribution of Violet® Iodine at Kroger Subsidiary
PR Newswire - Tue Jul 28, 7:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) today announced that its product to address premenstrual breast discomfort, Violet® iodine, will soon be available through a wholly owned subsidiary of The Kroger Co. (NYSE: KR), the largest U.S. grocery retailer.
KR: 38.03 (+0.03), BPMX: 1.19 (-0.01)
BioPharmX Corporation Launches #HugsShouldntHurt Social Media Campaign
PR Newswire - Fri Jul 17, 7:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) is excited to announce the launch of its social media campaign, #HugsShouldntHurt, to help generate brand awareness for its first consumer brand, Violet® iodine.
BPMX: 1.19 (-0.01)
OTC Markets Group Announces Second Quarter 2015 Index Performance and Rebalancing
PR Newswire - Thu Jul 16, 6:00AM CDT
OTC Markets Group Inc. ("OTC Markets Group" or "the Company"
(OTCQX: OTCM) today announced the second quarter 2015 performance and quarterly rebalancing of the OTCQX® indexes, the OTCQB® Venture Index, the OTCM QX ADR Index ("OTCQX30" and the OTCM ADR Index.
CETX: 2.75 (-0.08), PIRS: 1.95 (+0.09), RELY: 9.86 (+0.30), CRBP: 1.88 (unch), ONCS: 4.30 (-0.04), CYNA: 15.87 (+0.26), BPMX: 1.19 (-0.01), CXRX: 37.02 (+1.93)
BioPharmX To Ring New York Stock Exchange Opening Bell To Celebrate Its Listing On NYSE MKT
PR Newswire - Mon Jul 13, 7:30AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), is pleased to announce that the company's chief executive officer and its president are invited by the New York Stock Exchange (NYSE) to ring the NYSE Opening Bell® on Wednesday, July 15, 2015 to celebrate its listing. Its stock was uplisted and commenced trading on June 25, 2015.
BPMX: 1.19 (-0.01)
Cleavage vs. Cover-up: New Study Sponsored By Violet® iodine Reveals 73 percent of American Women Aren't Looking to Show-off 'The Girls'
PR Newswire - Wed Jul 08, 8:22AM CDT
If you've got them, flaunt them, right? Well, that's now only true for 27% of American women according to a new survey conducted by Newlio for Violet® iodine. In fact, this summer, the top swimsuit choice will be a one-piece (51 percent), followed by a tankini (18 percent), and a bikini (13 percent). Modesty may be on the rise this season, but the majority of women (73%) are perfectly happy with their cup sizes.
BPMX: 1.19 (-0.01)
BioPharmX Corporation Closes Underwritten Public Offering of Common Stock
PR Newswire - Wed Jul 01, 6:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) today announced the closing of its previously announced underwritten public offering of 3,636,364 shares of its common stock at a price to the public of $2.75 per share. BioPharmX has granted the underwriters a 30-day option to purchase up to 545,454 additional shares of common stock at the public offering price.
BPMX: 1.19 (-0.01)
U.S. IPO Weekly Recap: Year's Hottest Deal Pops 186% In Year's Most Active Week With 13 IPOs
Renaissance Capital IPO Research - at Seeking Alpha - Sat Jun 27, 11:49AM CDT
Things just got Seres in the IPO market. Thirteen companies went public this past week , more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its debut - the highest first-day pop since January 2014. The thirteen IPOs...
XTLY: 9.42 (-0.13), TRU: 25.00 (+0.05), CATB: 7.66 (-0.10), GNRT: 12.03 (+0.28), GPP: 14.32 (+0.81), GKOS: 20.68 (-0.17), APPF: 19.64 (+1.14), YECO: 2.61 (-0.05), MCRN: 18.33 (-0.03), LNTH: 3.63 (-0.10), BPMX: 1.19 (-0.01), ALRM: 12.56 (+0.01), MCRB: 29.80 (+0.58)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jun 25, 11:45AM CDT
CNXR: 4.85 (+0.17), TROV: 5.72 (+0.11), CNR: 0.95 (unch), CVSL: 1.74 (unch), NR: 6.57 (-0.03), SSE: 1.73 (+0.04), ATAI: 3.10 (-0.06), KIQ: 1.56 (+0.01), OPGN: 2.40 (-0.14), DSKX: 2.95 (+0.33), TRU: 25.00 (+0.05), HCA: 77.91 (+1.25), THC: 37.29 (+0.03), ISSC: 2.69 (unch), IKGH: 1.67 (+0.03), DPW: 0.71 (-0.02), SIXD: 2.90 (-0.10), BPMX: 1.19 (-0.01), OGEN: 1.60 (-0.03)
BIOPHARMX CORPORATION UPLISTS TO NYSE MKT (BPMX)
PR Newswire - Thu Jun 25, 6:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focused on the development of proprietary drug delivery products, today announced the pricing of a public offering of 3,636,364 shares of common stock at a price to the public of $2.75 per share for an aggregate offering amount of $10 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the company. In addition, BioPharmX has granted the underwriters a 30-day option to purchase up to 545,454 additional shares of common stock at the public offering price. In conjunction with the pricing of the offering, the company is simultaneously uplisting to the NYSE MKT today, and begins trading under the ticker symbol "BPMX." All shares of common stock to be sold in the offering are being offered by BioPharmX. The offering is expected to close on or about June 30, 2015, subject to customary closing conditions.
BPMX: 1.19 (-0.01)
BioPharmX begins trading on the NYSE MKT
M2 - Thu Jun 11, 12:15PM CDT
Companies mentioned in this article: BioPharmX Corporation (OTCQB: BPMX), DAVIDsTEA Inc. (NASDAQ: DTEA), Evolent Health Inc. (NYSE: EVH), EndoChoice Holdings (NYSE: GI), and PennTex Midstream Partners, LP (NASDAQ: PTXP)
DTEA: 16.19 (-0.97), EVH: 15.28 (-0.30), BPMX: 1.19 (-0.01), PTXP: 18.04 (+0.24), GI: 12.06 (+0.07)
BioPharmX on deck for IPO
Seeking Alpha - at Seeking Alpha - Thu Jun 11, 12:06PM CDT
BPMX: 1.19 (-0.01)
BioPharmX to uplist to the NYSE MKT, via APO, while PennTex is the next IPO
M2 - Tue Jun 02, 8:26AM CDT
Companies mentioned in this article: BioPharmX Corporation (OTCQB: BPMX), Source Financial Inc. (SRCF), PennTex Midstream Partners, LP (NASDAQ: PTXP), Memorial Resource Development Corp. (NASDAQ: MRD), and Shopify Inc. (NYSE: SHOP)
SHOP: 37.02 (-1.22), MRD: 19.39 (-0.39), BPMX: 1.19 (-0.01), PTXP: 18.04 (+0.24)
BioPharmX Corporation Expands Management Team to Support Growth and Market Expansion
PR Newswire - Tue Sep 29, 8:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focusing on women's health and dermatology, today announced the appointment of two executives to strengthen the company's operations and marketing efforts.
BPMX: 1.19 (-0.01)
StockNewsNow.com Publishes New SNNLive Video Interview With BioPharmX Corporation
Marketwired - Thu Sep 24, 7:00AM CDT
StockNewsNow.com, The Official MicroCap News Source(TM), today published an SNNLive Video Interview with Jim Pekarsky, CEO of BioPharmX Corporation (NYSE MKT: BPMX), a Silicon Valley-based specialty pharmaceutical company, according to the company's website (see here: www.BioPharmX.com). The video interview was recorded on Wednesday, Sept. 9, 2015 in New York City.
BPMX: 1.19 (-0.01)
Survey Shows Most U.S. Women Suffer from Premenstrual Breast Discomfort
PR Newswire - Tue Sep 22, 6:30AM CDT
As the public focuses on breast health in advance of Breast Cancer Awareness Month, newly released survey results find that most American women endure breast discomfort during their menstrual years, but do not know how to treat it or improve the health of their breasts.
BPMX: 1.19 (-0.01)
BioPharmX Corporation Reports Second Quarter Results
PR Newswire - Mon Sep 14, 3:05PM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a Silicon Valley-based specialty pharmaceutical company, today announced its financial results for the fiscal quarter ended July 31, 2015. An earnings conference call is scheduled for today at 4:30 p.m. Eastern Time.
BPMX: 1.19 (-0.01)
BioPharmX Corporation to Release Second Quarter 2016 Financial Results
PR Newswire - Wed Sep 09, 7:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) today announced it will release its financial results for second quarter ended July 31, 2015 and will host an earnings conference call at 4:30 p.m. Eastern Time on Monday, September 14, 2015.
BPMX: 1.19 (-0.01)
Seasoned Silicon Valley Financial Executive Joins BioPharmX Corporation As Chief Financial Officer
PR Newswire - Wed Aug 12, 7:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a Silicon Valley-based specialty pharmaceutical company, has appointed 20-year finance veteran Greg Kitchener, to be executive vice president of finance and chief financial officer.
BPMX: 1.19 (-0.01)
BioPharmX Corporation Launches Grocery Store Distribution of Violet® Iodine at Kroger Subsidiary
PR Newswire - Tue Jul 28, 7:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) today announced that its product to address premenstrual breast discomfort, Violet® iodine, will soon be available through a wholly owned subsidiary of The Kroger Co. (NYSE: KR), the largest U.S. grocery retailer.
KR: 38.03 (+0.03), BPMX: 1.19 (-0.01)
BioPharmX Corporation Launches #HugsShouldntHurt Social Media Campaign
PR Newswire - Fri Jul 17, 7:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) is excited to announce the launch of its social media campaign, #HugsShouldntHurt, to help generate brand awareness for its first consumer brand, Violet® iodine.
BPMX: 1.19 (-0.01)
OTC Markets Group Announces Second Quarter 2015 Index Performance and Rebalancing
PR Newswire - Thu Jul 16, 6:00AM CDT
OTC Markets Group Inc. ("OTC Markets Group" or "the Company"
(OTCQX: OTCM) today announced the second quarter 2015 performance and quarterly rebalancing of the OTCQX® indexes, the OTCQB® Venture Index, the OTCM QX ADR Index ("OTCQX30" and the OTCM ADR Index. CETX: 2.75 (-0.08), PIRS: 1.95 (+0.09), RELY: 9.86 (+0.30), CRBP: 1.88 (unch), ONCS: 4.30 (-0.04), CYNA: 15.87 (+0.26), BPMX: 1.19 (-0.01), CXRX: 37.02 (+1.93)
BioPharmX To Ring New York Stock Exchange Opening Bell To Celebrate Its Listing On NYSE MKT
PR Newswire - Mon Jul 13, 7:30AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), is pleased to announce that the company's chief executive officer and its president are invited by the New York Stock Exchange (NYSE) to ring the NYSE Opening Bell® on Wednesday, July 15, 2015 to celebrate its listing. Its stock was uplisted and commenced trading on June 25, 2015.
BPMX: 1.19 (-0.01)
Cleavage vs. Cover-up: New Study Sponsored By Violet® iodine Reveals 73 percent of American Women Aren't Looking to Show-off 'The Girls'
PR Newswire - Wed Jul 08, 8:22AM CDT
If you've got them, flaunt them, right? Well, that's now only true for 27% of American women according to a new survey conducted by Newlio for Violet® iodine. In fact, this summer, the top swimsuit choice will be a one-piece (51 percent), followed by a tankini (18 percent), and a bikini (13 percent). Modesty may be on the rise this season, but the majority of women (73%) are perfectly happy with their cup sizes.
BPMX: 1.19 (-0.01)
BioPharmX Corporation Closes Underwritten Public Offering of Common Stock
PR Newswire - Wed Jul 01, 6:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX) today announced the closing of its previously announced underwritten public offering of 3,636,364 shares of its common stock at a price to the public of $2.75 per share. BioPharmX has granted the underwriters a 30-day option to purchase up to 545,454 additional shares of common stock at the public offering price.
BPMX: 1.19 (-0.01)
U.S. IPO Weekly Recap: Year's Hottest Deal Pops 186% In Year's Most Active Week With 13 IPOs
Renaissance Capital IPO Research - at Seeking Alpha - Sat Jun 27, 11:49AM CDT
Things just got Seres in the IPO market. Thirteen companies went public this past week , more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its debut - the highest first-day pop since January 2014. The thirteen IPOs...
XTLY: 9.42 (-0.13), TRU: 25.00 (+0.05), CATB: 7.66 (-0.10), GNRT: 12.03 (+0.28), GPP: 14.32 (+0.81), GKOS: 20.68 (-0.17), APPF: 19.64 (+1.14), YECO: 2.61 (-0.05), MCRN: 18.33 (-0.03), LNTH: 3.63 (-0.10), BPMX: 1.19 (-0.01), ALRM: 12.56 (+0.01), MCRB: 29.80 (+0.58)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jun 25, 11:45AM CDT
CNXR: 4.85 (+0.17), TROV: 5.72 (+0.11), CNR: 0.95 (unch), CVSL: 1.74 (unch), NR: 6.57 (-0.03), SSE: 1.73 (+0.04), ATAI: 3.10 (-0.06), KIQ: 1.56 (+0.01), OPGN: 2.40 (-0.14), DSKX: 2.95 (+0.33), TRU: 25.00 (+0.05), HCA: 77.91 (+1.25), THC: 37.29 (+0.03), ISSC: 2.69 (unch), IKGH: 1.67 (+0.03), DPW: 0.71 (-0.02), SIXD: 2.90 (-0.10), BPMX: 1.19 (-0.01), OGEN: 1.60 (-0.03)
BIOPHARMX CORPORATION UPLISTS TO NYSE MKT (BPMX)
PR Newswire - Thu Jun 25, 6:00AM CDT
BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company focused on the development of proprietary drug delivery products, today announced the pricing of a public offering of 3,636,364 shares of common stock at a price to the public of $2.75 per share for an aggregate offering amount of $10 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the company. In addition, BioPharmX has granted the underwriters a 30-day option to purchase up to 545,454 additional shares of common stock at the public offering price. In conjunction with the pricing of the offering, the company is simultaneously uplisting to the NYSE MKT today, and begins trading under the ticker symbol "BPMX." All shares of common stock to be sold in the offering are being offered by BioPharmX. The offering is expected to close on or about June 30, 2015, subject to customary closing conditions.
BPMX: 1.19 (-0.01)
BioPharmX begins trading on the NYSE MKT
M2 - Thu Jun 11, 12:15PM CDT
Companies mentioned in this article: BioPharmX Corporation (OTCQB: BPMX), DAVIDsTEA Inc. (NASDAQ: DTEA), Evolent Health Inc. (NYSE: EVH), EndoChoice Holdings (NYSE: GI), and PennTex Midstream Partners, LP (NASDAQ: PTXP)
DTEA: 16.19 (-0.97), EVH: 15.28 (-0.30), BPMX: 1.19 (-0.01), PTXP: 18.04 (+0.24), GI: 12.06 (+0.07)
BioPharmX on deck for IPO
Seeking Alpha - at Seeking Alpha - Thu Jun 11, 12:06PM CDT
BPMX: 1.19 (-0.01)
BioPharmX to uplist to the NYSE MKT, via APO, while PennTex is the next IPO
M2 - Tue Jun 02, 8:26AM CDT
Companies mentioned in this article: BioPharmX Corporation (OTCQB: BPMX), Source Financial Inc. (SRCF), PennTex Midstream Partners, LP (NASDAQ: PTXP), Memorial Resource Development Corp. (NASDAQ: MRD), and Shopify Inc. (NYSE: SHOP)
SHOP: 37.02 (-1.22), MRD: 19.39 (-0.39), BPMX: 1.19 (-0.01), PTXP: 18.04 (+0.24)
